در هنگام جستجو کلمه در قسمت عنوان میتوانید کلمات مورد جستجو را با کاراکتر (-) جدا کنید.
کاربرد نوع شرط:
- جایگاه : پژوهشی
- مجله: Interdisciplinary Journal of Virtual Learning in Medical Sciences
- نوع مقاله: Journal Article
- کلمات کلیدی: Quality Control,Hospital,educational assessment,Educational Management,Baldrige Model
- چکیده:
- چکیده انگلیسی: Introduction: Quality improvement is one of the important challenges of health systems. Baldrige excellence model, which makes use of self-assessment mechanisms to promote organizations, has optimized the principles of Total Quality Management (TQM) to improve the quality in teaching and treatment organizations. The aim of the present study was to evaluate the clinical and educational system of the teaching hospital based on Baldrige Excellence Model.Materials and Methods: This study was a descriptive-analytical, cross-sectional survey conducted in the Baqiyatallah hospital in Tehran in 2011. The data were collected based on Baldrige questionnaire (version2009-2010) through interviewing the educational managers and the staff, studying the recorded documents and observing the processes. The scores were calculated based on Baldrige Vote matrix, and Excel 2007 software was used to analyze the data.Results: The selected hospital obtained 332.94 (33.2%) points out of 1000 in the Baldrige modeling clinical-educational section. Organizational leadership criterion with 53.95 out of 120 points (44.96%) and performance results criterion with 109 out of 450 points (24.44%) were the strongest and weakest in this hospital, respectively.Conclusion: Despite the fact that, due to the implementation of WFME, this center has an appropriate approach for excellence, it is in need of further improvement at the levels of learning and organizational integration. We recommend the use of advanced sections capabilities for organizational integration and the reinforcement of current accreditation system based on Baldrige Model criteria.
- انتشار مقاله: 11-10-1398
- نویسندگان: Mohammad Saleh Fallah,Nooredin Dopeykar,Shahram Tofighi,Zahra Azami Alvand,Hosien Amini Anabod,Mohsen Barouni,Mojtaba Khajehazad,Nourolhoda Fakhrzad
- مشاهده
- جایگاه : پژوهشی
- مجله: Iranian Journal of Pharmaceutical Sciences
- نوع مقاله: Journal Article
- کلمات کلیدی: Ulcerative colitis,Cost-effectiveness analysis,Economic Evaluation,Infliximab,Conventional treatments,Incremental cost-effectiveness ratio
- چکیده:
- چکیده انگلیسی: The aim of this study is to assess cost-effectiveness of infliximab, compared with conventional treatments in patients with moderate to severe Ulcerative Colitis (UC) in Iran. We developed an analytical decision model with a 5-year-time horizon to follow up 1000 hypothetical patients, in order to estimate treatment costs and outcomes. Hypothetical patients, were individuals with moderate to severe UC, that are resistant to conventional treatments. Remission rate, clinical response, and surgery, were selected as clinical outcomes. For estimating QALY, utility value related to each state, drive form published paper. We also estimated associated probabilities by using patients ’medical records and specialists’ opinion. Costs of treatment such as: Physician visit fee, laboratory tests, hospitalizations, surgery, and drugs were estimated based on the public sector tariffs and drug price list that set by pricing committee of food and drug administration. Infliximab costs at dosage of 5 mg /kg, were considered for UC patients with average weight of 75 kilogram. Incremental Cost-Effectiveness Ratio (ICER) of infliximab treatment in UC patients were 240,903 USD dollars per QALY gained, compared with conventional treatments. According to recommendation of World Health Organization for choosing cost-effective intervention, interventions with relative cost-effectiveness value less than 3 times of Gross Domestic Production (GDP) per capita, are cost–effective. Our result showed that the ICER value of infliximab, is approximately 51 times of Iran’s local GDP per capita, in 2014 – i.e. more than 3 time GDP per capita. Thus, for UC patients, our finding indicates, infliximab, is not a cost- effective treatment.
- انتشار مقاله: 30-07-1394
- نویسندگان: Najmeh Moradi,Shahram Tofighi,Marzieh Zanganeh,Ali Akbari Sari,Hossein Khedmat,Leila Zarei
- مشاهده
- جایگاه : پژوهشی
- مجله: International Journal of Travel Medicine and Global Health
- نوع مقاله: Journal Article
- کلمات کلیدی: mortality,patients,Intensive Care Unit,Quality of health care,APACHE
- چکیده:
- چکیده انگلیسی: Introduction: Improving the health level of patients is one of the most important purposes in intensive care units. In order to promote these units we need to measure their quality. To do so, some standards are needed in this area. The aim of this article was to study the mortality rate of the patients admitted to intensive care units with different APACHE scores.
Methods: This descriptive and retrospective study was conducted in Tehran, Iran. The sampling was census and all the patients who had been admitted to the intensive care unit in a hospital in Tehran in 2013 were studied in this study. The overall admitted patients were 350 that only 318 patients had completed the records and were involved in the study. Data was analyzed by using SPSS15.
Results: Mortality and viability in these two groups were 122 and 196, respectively. Seven out of 68 with scores 20, the mortality rate was 25% which was higher than standard values.
Conclusion: According to the obtained results, we can conclude that the quality of care in intensive care units is desirable. It can be said that according to the APACHE system the quality of healthcare is desirable in the Intensive Care Units. As a conclusion, in order to promote quality, more serious care is needed in patients with greater scores.- انتشار مقاله: 15-11-1393
- نویسندگان: Manaf Abdi,Shahram Tofighi,Sharareh Niakan-Kalhori,Abbas Ebadi,Rohollah Zaboli,Mohammad Hossein Basirat,Esmaeil Feyzi
- مشاهده
- جایگاه : پژوهشی
- مجله: International Journal of Travel Medicine and Global Health
- نوع مقاله: Journal Article
- کلمات کلیدی: Iran,Health Insurance,Health benefit Plans,Medical Service Insurance Organization
- چکیده:
- چکیده انگلیسی: Introduction: Development of Complementary Health Insurance (CHI) benefit packages has always been one of the main challenges of Health Insurance Organizations in Iran. Records related to developing a health insurance package in Iran show that there is no specific criterion for developing such packages. This study aimed at developing criteria for providing CHI benefit packages presented by the Medical Service Insurance Organization in Iran.
Methods: The current research is a qualitative and applied research which has been conducted in 2014. The sample size included 24 authorities in the domain of CHI, and a semi-structured interview was used for collecting data. Data analysis was based on framework method applying Atlas-Ti 5.2 software.
Results: Nineteen main themes and 53 sub-themes and finally 20 criteria were identified for four main dimensions of the benefit package including the insured, commitments of insurance services, financial resources and Medical Service Insurance Organization special priorities.
Conclusion: In this study, various criteria were identified for developing CHI. It seems that applying important criteria such as equity, clinical guidelines, effectiveness, and efficiency of CHI benefit package presented by Medical Service Insurance Organization can decrease the shortcomings of the current system and using standardization can lead to targeting the service benefit package, removing its defects and improving the health of insured people.- انتشار مقاله: 05-03-1394
- نویسندگان: Nasser Saravi,Rohollah Zaboli,Ali Hassanzadeh,Farshad Najafipour,Aziz Rezapour,Majid Rezai-Rad,Shahram Tofighi
- مشاهده